Mark S Wathen

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. ncbi Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies
    Mark S Wathen
    Vanderbilt Page Campbell Heart Institute, Vanderbilt University Medical Center, 2220 Pierce, Nashville, TN 37232, USA
    Circulation 110:2591-6. 2004
  2. ncbi Frequency of late recurrence of intra-atrial reentry tachycardia after radiofrequency catheter ablation in patients with congenital heart disease
    Prince J Kannankeril
    Department of Medicine, Vanderbilty University Medical Center, Nashville, Tennessee 37232 2572, USA
    Am J Cardiol 92:879-81. 2003
  3. ncbi Incidence and characteristics of type-2 breaks in response to antitachycardia pacing therapy in implantable cardioverter defibrillator patients
    Vinod Sharma
    Tachyarrhythmia Research, Medtronic Inc, 7000 Central Avenue N E, Minneapolis, MN 55432, USA
    J Cardiovasc Electrophysiol 14:1156-62. 2003
  4. ncbi Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial
    Michael O Sweeney
    Cardiac Arrhythmia Service, Brigham and Women s Hospital and Harvard Medical School, Boston, Mass 02115, USA
    Circulation 111:2898-905. 2005
  5. ncbi QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators
    Alfred E Buxton
    Cardiology Division, Department of Medicine, Brown Medical School, Providence, Rhode Island 02905, USA
    J Am Coll Cardiol 46:310-6. 2005
  6. ncbi Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study
    Bruce L Wilkoff
    Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Director of Cardiac Pacing and Tachyarrhythmia Devices, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F 15, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 52:541-50. 2008

Detail Information

Publications6

  1. ncbi Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies
    Mark S Wathen
    Vanderbilt Page Campbell Heart Institute, Vanderbilt University Medical Center, 2220 Pierce, Nashville, TN 37232, USA
    Circulation 110:2591-6. 2004
    ..Fast VT (FVT) >200 bpm is often treated by shock because of safety concerns, however. This prospective, randomized, multicenter trial compares the safety and utility of empirical ATP with shocks for FVT in a broad ICD population...
  2. ncbi Frequency of late recurrence of intra-atrial reentry tachycardia after radiofrequency catheter ablation in patients with congenital heart disease
    Prince J Kannankeril
    Department of Medicine, Vanderbilty University Medical Center, Nashville, Tennessee 37232 2572, USA
    Am J Cardiol 92:879-81. 2003
    ..Of the 23 patients who were free of recurrence 1 year after ablation, 21 (91%) remain free from recurrence at an average of 45 months (median 39; range 15 to 88) after ablation...
  3. ncbi Incidence and characteristics of type-2 breaks in response to antitachycardia pacing therapy in implantable cardioverter defibrillator patients
    Vinod Sharma
    Tachyarrhythmia Research, Medtronic Inc, 7000 Central Avenue N E, Minneapolis, MN 55432, USA
    J Cardiovasc Electrophysiol 14:1156-62. 2003
    ..We investigated the prevalence and characteristics of type-2 breaks in ICD patients...
  4. ncbi Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial
    Michael O Sweeney
    Cardiac Arrhythmia Service, Brigham and Women s Hospital and Harvard Medical School, Boston, Mass 02115, USA
    Circulation 111:2898-905. 2005
    ....
  5. ncbi QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators
    Alfred E Buxton
    Cardiology Division, Department of Medicine, Brown Medical School, Providence, Rhode Island 02905, USA
    J Am Coll Cardiol 46:310-6. 2005
    ..The utility of QRSd to predict VT/VF events in patients with CAD requires further prospective evaluation...
  6. ncbi Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study
    Bruce L Wilkoff
    Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Director of Cardiac Pacing and Tachyarrhythmia Devices, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F 15, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 52:541-50. 2008
    ....